Bruker to pay $2.4m to settle SEC charge of improper payments in China
Bruker Corp will pay $2.4m to settle US SEC charges that employees improperly funded Chinese officials' sightseeing trips to win analytical tech contracts at state labs.
Archives for December 16, 2014
Baxter exits vaccines business as it preps for biopharma spinout
Baxter has sold its pandemic flu portfolio and Vero cell technology to Nanotherapeutics in preparation for the launch of its haematology and oncology-based spinout company Baxalta.
Singapore develops plan to support influx of biomanufacturing
Industry heavyweights and Singaporean development groups have unveiled a five-year roadmap to deal with the need for more employees in the fast-growing biologics manufacturing industry on the island.